Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors | news.google.com • |
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors | news.google.com • |
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors | news.google.com • |
INOVIO to Present at Upcoming Scientific Conference | news.google.com • |
INOVIO to Present at Upcoming Scientific Conference | prnewswire.com • |
INOVIO to Present at Upcoming Scientific Conference | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-08 | 2024-06 | -1.15 | -1.19 | -0.04 | -3.48% |
2024-05-13 | 2024-03 | -1.08 | -1.31 | -0.23 | -21.30% |
2024-03-06 | 2023-12 | -1.58 | N/A | N/A | N/A |
2023-11-09 | 2023-09 | -1.56 | -1.08 | 0.48 | 30.77% |
2023-08-09 | 2023-06 | -1.68 | -1.56 | 0.12 | 7.14% |
2023-05-10 | 2023-03 | -1.68 | -1.92 | -0.24 | -14.29% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-05-10 | RBC Capital | Upgrade | Sector Perform | Sector Perform |
2023-03-01 | RBC Capital | Upgrade | Sector Perform | |
2022-11-08 | Maxim Group | Downgrade | Buy | Hold |
2022-10-31 | B of A Securities | Downgrade | Neutral | Underperform |
2022-08-09 | RBC Capital | Upgrade | Sector Perform | |
2022-05-10 | Oppenheimer | Downgrade | Outperform | Perform |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-05-14 | BENITO SIMON X | Director | 10.02K | Conversion of Exercise of derivative security |
2024-05-14 | DANSEY ROGER D | Director | 6.75K | Conversion of Exercise of derivative security |
2024-05-14 | HUMEAU LAURENT M | Officer | 24.34K | Conversion of Exercise of derivative security |
2024-05-14 | KIES PETER D | Chief Financial Officer | 24.74K | Conversion of Exercise of derivative security |
2024-05-14 | MILLER ANN CALBY M.D. | Director | 7.71K | Conversion of Exercise of derivative security |
2024-05-14 | SHEPARD JAY P. | Director | 7.04K | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 20.07M | 8.96M | 7.49% |
2023-06-29 | Shaw D.E. & Co., Inc. | 7.60M | 3.39M | 2.84% |
2023-06-29 | Blackrock Inc. | 6.09M | 2.72M | 2.27% |
2023-06-29 | Renaissance Technologies, LLC | 5.44M | 2.43M | 2.03% |
2023-06-29 | Millennium Management Llc | 5.34M | 2.38M | 1.99% |
2023-06-29 | Jane Street Group, LLC | 3.20M | 1.43M | 1.19% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 8.26M | 3.69M | 3.08% |
2023-06-29 | Vanguard Horizon Fund-Strategic Small-Cap Equity Fund | 4.06M | 1.81M | 1.51% |
2023-06-29 | Vanguard Extended Market Index Fund | 3.35M | 1.50M | 1.25% |
2023-06-29 | Vanguard Strategic Equity Fund | 3.00M | 1.34M | 1.12% |
2023-08-30 | iShares NASDAQ Biotechnology ETF | 1.88M | 844.39K | 0.70% |
2023-05-30 | Fidelity Extended Market Index Fund | 1.27M | 761.76K | 0.47% |
Dividend | Date |
---|---|
0.0057 | 2017-09-28 |
0.0057 | 2017-08-29 |
0.0057 | 2017-07-27 |
0.0057 | 2017-06-28 |
Split | Date |
---|---|
1 : 12 | 2024-01-25 |
1 : 4 | 2014-06-06 |
1 : 4 | 2014-06-05 |
0.25 : 1 | 2004-09-13 |
-
WHAT THE FUCK HAPPENED?! This ruined my portfolio if it doesnt uptrend at open. I got out of $SRNE & literally every other position just for this to tank and ruin me for the month. Idk wtf has happened but Kim, the DoD and a bunch of mf’s have got to explain. Hopefully my shares will be sold right at open and i wont suffer a catastrophic loss that i cannot afford rn. Who wants to file a complaint and lawsuit? Where do we go? Lmfao
-
$INO what’s wrong!! This is normal read the full news bellow: Temporary hold not FDA Puts INOVIO's IND For Phase 2/3 Trial Of COVID-19 Vaccine Candidate On Partial Clinical Hold
Contributor Sep 28, 2020 7:17AM EDT
(RTTNews) - Biotechnology company INOVIO (INO) announced Monday that the U.S. Food and Drug Administration (FDA) has notified the company that it has additional questions about the company's planned Phase 2/3 trial of its COVID-19 vaccine candidate INO-4800, including its CELLECTRA 2000 delivery device to be used in the trial.Until the FDA's questions have been satisfactorily addressed, INOVIO's Investigational New Drug Application (IND) for the Phase 2/3 trial is on partial clinical hold.
The company is actively working to address the FDA's questions and plans to respond in October, after which the FDA will have up to 30 days to notify INOVIO of its decision as to whether the trial may proceed.
This partial clinical hold is not due to the occurrence of any adverse events related to INOVIO's ongoing expanded Phase 1 study of INO-4800, the conduct of which may continue and is not impacted by the FDA's notification.
INOVIO and its partners are continuing to prepare for a planned Phase 2/3 trial of INO-4800, following resolution of the FDA's partial clinical hold and subject to the receipt of external funding to conduct the trial.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
-
-
bad news sell all
-
Fuck your whole family kim
-
What’s this all about is this a buying point
-
All this $INO news, i want if to reflect by the end of this month!
-
Still 1/3 of the avg vol. high potential here
-
Finally a chance to check vaccine results!! Sept 27th mark your calendar!! GO BNTX/PFE! https://www.google.com/amp/s/www.bloombergquint.com/amp/coronavirus-outbreak/pfizer-s-covid-vaccine-trial-plan-may-beat-rivals-to-early-look
-
15.98 in Frankfurt.
-
Lol dropped 26 cents out of left field typical action of weak hands
-
Someone post a citron headshot
-
Andd here’s the short
-
Seruously fuck you kim
-
Man i hope today is the day
-
He’a calling out citron about sample pop lmao
-
@timDonald i feel you to the max lol
-
Wish i didn’t sell before the dip but back in at 17.97
-
To my INO friends, get LCA before it pops this week.
-
INOVIO to Present at Upcoming Scientific Conference
news.google.com • -
INOVIO to Present at Upcoming Scientific Conference
prnewswire.com • -
INOVIO to Present at Upcoming Scientific Conference
news.google.com •